Hi nmusers, Roivant Sciences is seeking candidates for a 1 year clinical pharmacology fellowship program in their Durham, North Carolina, office. Roivant Sciences is a biopharmaceutical company focused on realizing the full value of promising drug candidates and systematically reducing the time and cost of delivering new drugs to market. This fellowship will provide a broad overview and real-world experience of the drug development process. We are seeking self-motivated graduates who are passionate about pursuing a research career within the pharmaceutical industry. GENERAL INFORMATION:
* This is a 1 year program located in Durham, NC. The estimated start date is 5/16/2018 (flexible). * The selected fellow is responsible for his/her relocation, housing and transportation. * Fellows will be paid a competitive salary and are eligible for company benefits. BASIC QUALIFICATIONS * High energy, self-directed individuals with excellent communication skills * Completed a U.S. based PharmD or PhD degree program in Pharmacokinetics, Biology, Pharmaceutics, or a related field. * Candidates must be eligible to work in the US at the time of, and for the duration of their employment. Candidates will be required to furnish evidence of US work authorization. To see additional details and application form, click this link https://boards.greenhouse.io/roivantsciences/jobs/852798?gh_jid=852798#.WdKXZmhSyUk or go to Roivant.com and click 'Join us' Brendan M. Johnson, Ph.D. Senior Director, Pharmacokinetics Roivant Sciences, Inc. 324 Blackwell St, Suite 1220, Durham, NC 27701 [email protected]<mailto:[email protected]> office: +1 (919) 425-5710 mobile:+1 (919) 572-9559 [cid:[email protected]] www.roivant.com<http://www.roivant.com/> This e-mail message (including all attachments) is for the sole use of the intended recipient(s) and may contain confidential and privileged information. If you are not the intended recipient, you must not review, use, disclose, copy, distribute or keep this email, its attachments or the message(s) or information contained in it or attached to it. If you are not the intended recipient, please contact the sender as soon as possible by reply e-mail and thereafter immediately delete this email and destroy all copies of the original message and any attachments. We have taken precautions to minimize the risk of transmitting software viruses, but we advise you to carry out your own virus checks on any attachment to this message. We cannot accept liability for any loss or damage caused by software viruses.
